COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF GLYCOPYRRONIUM BROMIDE VERSUS TIOTROPIUM BROMIDE AS A MAINTENANCE BRONCHODILATOR TREATMENT IN PATIENTS WITH MODEREATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

被引：0
|
作者：
Ruiz Miranda, C., I [1 ]
Ubiarco Lopez, V [1 ]
Chavez Plascencia, E. [1 ]
机构：
[1] Novartis Mexico, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS28
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [41] COST-MINIMIZATION ANALYSIS OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK
    Schroeder, M.
    Shah, D.
    Risebrough, N.
    Ndirangu, K.
    Martin, A. A.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S235 - S235
  • [42] Clinical study of doxophylline combined with tiotropium bromide inhalation in the treatment of chronic obstructive pulmonary disease
    Wen, Linlin
    Li, Fuqiang
    Li, Shufang
    Jiang, Shaochang
    MINERVA MEDICA, 2022, 113 (05) : 891 - 892
  • [43] Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease
    Haley, Ryan
    Gupta, Nita
    Sethi, Sanjay
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 103 - 113
  • [44] Comparative Effectiveness Of Budesonide/formoterol Combination (bfc) And Tiotropium Bromide Among Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment
    Strange, C. B.
    Racketa, J.
    Kern, D. M.
    Williams, S. A.
    Tunceli, O.
    Zhou, S.
    Graham, E.
    Trudo, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [45] Clarithromycin plus tiotropium bromide improves pulmonary and immune function in patients with chronic obstructive pulmonary disease
    Sheng, Meimei
    Zhao, Jian
    Dai, Na
    Xie, Daqi
    Weng, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (11): : 8234 - 8241
  • [46] Estimation of morbidity, resource utilization and cost in subjects treated with tiotropium bromide for chronic obstructive pulmonary disease (COPD) in a Spanish population setting
    Sicras, A.
    Navarro, R.
    De Haro, L.
    Serrat, J.
    Llopart, J. R.
    Velasco, S.
    VALUE IN HEALTH, 2006, 9 (06) : A262 - A262
  • [47] Efficacy and Safety Analysis of Salmeterol/Fluticasone Propionate with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease
    Zhang, Zili
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 128 - 133
  • [48] Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
    Eklund, Oskar
    Afzal, Faraz
    Borgstrom, Fredrik
    Flavin, Jason
    Ternouth, Andrew
    Ojanguren, Maria Eugenia
    Crespo, Carlos
    Baldwin, Mike
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 243 - 252
  • [49] Bronchodilator Effect of Tiotropium via Respimat ® Administered with a Spacer in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Ogasawara, Takashi
    Sakata, Jun
    Aoshima, Yoichiro
    Tanaka, Kazuki
    Yano, Toshiaki
    Kasamatsu, Norio
    INTERNAL MEDICINE, 2017, 56 (18) : 2401 - 2406
  • [50] Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease
    Tao Wang
    Guangwei Luo
    Yi Hu
    Fajiu Li
    Jing Ma
    Jianmiao Wang
    Peng Zuo
    Weining Xiong
    Xiansheng Liu
    Jianping Zhao
    Shengdao Xiong
    Zhenxiang Zhang
    Chenghong Li
    Su Zhao
    Jiemin Sun
    Yongjian Xu
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 : 614 - 618
12345